Anzeige
Mehr »
Login
Dienstag, 25.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Gold-Highflyer startet durch - Mega-Bohrprogramm sorgt für Kursfantasie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17.03.AstraZeneca's $800M rare disease bet hits primary phase 3 goal, but competitive strength still unclear
14.03.MicroTransponder nets $65M for stroke rehabilitation neurostimulator
14.03.Oligomerix small molecule tamps down tau tangles, improves coordination in mice
14.03.Pliant, Acelyrin resort to 'poison pills' as threat of Concentra buyout looms
14.03.Sutro discards CEO, 50% of staff, sole clinical-stage ADC and manufacturing site to save cash
13.03.George Church spinout GRObio explores strategic alternatives 6 months after $60M series B
13.03.Researchers identify potential MASH target after gene disruption triggers liver symptoms in mice
13.03.Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M
13.03.NIH allegedly cancels dozens of grants for vaccine hesitancy research: reports
13.03.Takeda's oncology execs sharpen focus after restructuring
13.03.Sotio takes up option on ADCs, Boehringer inks discovery pact
13.03.Hologen AI commits $430M to MeiraGTx Parkinson's gene therapy
13.03.Eye surgery specialist BVI Medical claims $1B capital raise
13.03.ImmunoPrecise teases $10M ADC collab with major biotech
12.03.Clario acquires WCG's neuroscience-focused clinical outcome assessment business
12.03.GSK posts data on HIV assets vying for roles in 6-month combo
12.03.J&J's Monarch bronchoscopy robot cleared by FDA to connect to live CT scans
12.03.Insilico Medicine raises $110M for new trials and robotic helping hands
12.03.Manufacturer fuels Swiss biotech's next-gen vaccine portfolio in new investment deal
12.03.Harbour BioMed launches new obesity biotech on mission to preserve muscle mass
12.03.Ono pays $280M upfront for Ionis' antisense oligonucleotide for rare blood cancer
12.03.Roche pads out obesity pipeline, paying Zealand Pharma $1.6B upfront to codevelop amylin asset
11.03.NIH grants powered $94B in economic activity in 2024 and supported more than 400,000 jobs: report
11.03.Siemens Healthineers expands photon-counting CT family with new FDA clearances
11.03.Illumina aims to cut $100M in costs following China import ban